FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Pioglitazone/Metformin HCl (ACTOPLUS MET®) Tablets
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Takeda Pharmaceuticals USA Inc. (New 10/18/2021)

Company Contact Information:

Presentation Posting Date Related Information
15mg/500mg tablet (NDC 64764-0155-60) 10/18/2021 Business reasons for discontinuation

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English